Valuation: Terumo Corporation

Market Cap 3,541B 22.15B 20.07B 18.56B 16.75B 31.56B 2,088B 32.67B 223B 88.41B 1,115B 83.1B 81.34B P/E 2027 *
39.2x
P/E 2028 * 18.7x
Enterprise Value 3,614B 22.61B 20.49B 18.95B 17.1B 32.22B 2,132B 33.35B 228B 90.26B 1,139B 84.84B 83.04B EV / Sales 2027 *
2.93x
EV / Sales 2028 * 2.68x
Free-Float
97.34%
Yield 2027 *
1.5%
Yield 2028 * 1.68%
1 day+1.77%
1 week-4.14%
Current month+1.58%
1 month+6.08%
3 months-6.77%
6 months+27.08%
Current year+7.60%
1 week 2,280
Extreme 2280
2,583.5
1 month 2,250
Extreme 2250
2,639.5
Current year 1,900
Extreme 1900
2,689
1 year 1,900
Extreme 1900
2,689
3 years 1,900
Extreme 1900
3,182
5 years 1,708
Extreme 1708
3,182
10 years 958.75
Extreme 958.75
3,182
Manager TitleAgeSince
Chief Executive Officer 62 31/03/2024
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 68 31/03/2022
Director/Board Member 63 20/06/2019
Director/Board Member 75 24/06/2020
Change 5-day change 1-year change 3-year change Capi.($)
+1.92%-4.14%+1.66%+3.26% 22.15B
+1.18%-1.28%-16.90%+10.73% 188B
+1.85%+1.04%+7.29%+38.96% 126B
-0.88%-4.98%-14.52%+9.17% 118B
+1.36%-5.91%-42.82%+2.34% 92.48B
+2.96%+7.64%-0.80%+85.81% 68.51B
+1.08%+2.90%+12.95%-6.73% 59.39B
+0.89%+4.17%+2.07%+52.91% 55.48B
+1.07%+4.08%+0.88%+49.64% 49.62B
+1.79%+0.10%-0.55%-3.19% 35.17B
Average +1.29%+0.17%-5.07%+24.29% 81B
Weighted average by Cap. +1.15%-0.48%-8.64%+23.40%

Financials

2027 *2028 *
Net sales 1,234B 7.72B 6.99B 6.47B 5.84B 11B 728B 11.39B 77.7B 30.81B 389B 28.96B 28.34B 1,321B 8.26B 7.48B 6.92B 6.25B 11.77B 779B 12.19B 83.17B 32.98B 416B 31B 30.34B
Net income 105B 657M 595M 550M 497M 936M 61.9B 969M 6.61B 2.62B 33.07B 2.46B 2.41B 190B 1.19B 1.07B 994M 897M 1.69B 112B 1.75B 11.94B 4.74B 59.74B 4.45B 4.36B
Net Debt 73.84B 462M 419M 387M 349M 658M 43.55B 681M 4.65B 1.84B 23.26B 1.73B 1.7B -2.11B -13.23M -11.99M -11.09M -10M -18.85M -1.25B -19.52M -133M -52.81M -666M -49.64M -48.59M
Projected Income Statement - Annual - Terumo Corporation
Logo Terumo Corporation
Terumo Corp is a Japan-based company mainly engaged in the manufacture and sale of medical devices and pharmaceuticals. The Company operates in three segments. The Cardiovascular Company segment provides guidewires for angiography, catheters for angiography, introducer sheaths, coils, stents and bag embolization devices for treatment of cerebral aneurysms, artificial lungs and artificial heart-lung machines. The Medical Care Solutions Company segment provides hospital care solutions, life care solutions, and pharmaceutical solutions. The Blood and Cell Technology Company segment provides blood bags, component blood collection systems, automated blood product systems, pathogen reduction systems, and centrifugal blood component separators.
Employees
30,591
Date Price Change Volume
16/11/26 JP¥2,446.00 +1.92% 1,584,700
13/11/26 JP¥2,400.00 -6.18% 13,588,700
12/11/26 JP¥2,558.00 +1.67% 4,568,100
11/11/26 JP¥2,516.00 +0.20% 5,038,700
10/11/26 JP¥2,511.00 -1.45% 4,818,900
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Terumo Corporation
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
2,400.00JPY
Average target price
2,970.00JPY
Spread / Average Target
+23.75%
  1. Stock Market
  2. Stocks
  3. 4543 Stock